Group One Trading, L.P. Adicet Bio, Inc. Transaction History
Group One Trading, L.P.
- $2.2 Billion
- Q1 2025
A detailed history of Group One Trading, L.P. transactions in Adicet Bio, Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 6,792 shares of ACET stock, worth $5,094. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,792
Previous 11,200
39.36%
Holding current value
$5,094
Previous $10,000
50.0%
% of portfolio
0.0%
Previous 0.0%
Shares
6 transactions
Others Institutions Holding ACET
# of Institutions
63Shares Held
57.5MCall Options Held
36.9KPut Options Held
16.5K-
Orbimed Advisors LLC San Diego, CA11.4MShares$8.59 Million0.27% of portfolio
-
Tang Capital Management LLC San Diego, CA8.22MShares$6.17 Million0.41% of portfolio
-
Ra Capital Management, L.P. Boston, MA7.54MShares$5.66 Million0.12% of portfolio
-
Goldman Sachs Group Inc New York, NY3.82MShares$2.86 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.21MShares$2.4 Million0.0% of portfolio
About Adicet Bio, Inc.
- Ticker ACET
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 40,030,800
- Market Cap $30M
- Description
- Adicet Bio, Inc., a biotechnology company, discovers and develops allogeneic gamma delta T cell therapies for cancer and other diseases. The company offers gamma delta T cells engineered with chimeric antigen receptors and T cell receptor-like antibodies to enhance selective tumor targeting, facilitate innate and adaptive anti-tumor immune respo...